Summary
This 8-K filing from IDEXX LABORATORIES INC /DE announces a change in its board of directors. Specifically, M. Anne Szostak was elected as a new director, filling a vacancy and increasing the size of Class II directors. Ms. Szostak will serve on the compensation committee, and her directorship term concludes at the 2014 annual meeting, with eligibility for election by stockholders for a three-year term thereafter. Investors should note that Ms. Szostak's compensation will align with that of other non-employee directors, with prorated cash fees for the current quarter and future stock unit and option grants. This appointment appears to be a routine governance update rather than a response to a specific event, but it signifies an addition to the company's leadership and oversight structure.
Key Highlights
- 1IDEXX LABORATORIES INC /DE elected M. Anne Szostak as a new director on July 10, 2012.
- 2Ms. Szostak has been appointed as a member of the company's compensation committee.
- 3Her election fills a vacancy in Class II of the board of directors, increasing its size from two to three.
- 4Ms. Szostak's initial term as a director concludes at the 2014 annual meeting.
- 5She will be eligible for election by stockholders at the 2014 Annual Meeting for a three-year term expiring in 2017.
- 6Ms. Szostak will receive compensation consistent with other non-employee directors, with prorated fees for the third quarter of 2012.
- 7Future stock unit and stock option grants to Ms. Szostak will be prorated from her election date to the 2013 annual meeting.